Emerging therapies offer hope for those with treatment-resistant depression

Studies show the pandemic -- and the isolation and uncertainty that came with it -- increased the number of people reporting symptoms of anxiety and depression. We explore some of the emerging therapies for people with treatment-resistant depression, including transcranial magnetic stimulation or TMS, ketamine therapy and psilocybin with Dr. Chris Schneck, medical director of the Helen and Arthur E. Johnson Depression Center at the Anschutz Medical Campus and professor of psychiatry at the CU School of Medicine. We also speak with Danielle Valks, who tried TMS for depression and her mood dramatically improved.